Ping An’s doctor has just completed A financing, but the money is probably enough for the general company to blend 5 times in C round. What factors support his $3 billion valuation? Last week, Ping An’s doctor held a press conference. The first was the follow-up strategic plan. The second was the official confirmation of the $500 million Series A financing, with a valuation of $3 billion. This is undoubtedly a sky-high price, even if it is consistent with the prospectus that was previously smashed, it is still a surprise. From the market level, Ping An is the first echelon in China, and the daily active data is bright (this data has also been proved by Questmobile), but the registered network and Chun Yu doctors who compete with it are also very strong. However, the valuation of Ping An's doctors is not only far superior to the previous round of valuation of the micro-medicine group based on registered networks (not to mention Dr. Chun Yu), and is unparalleled in the worldwide Internet medical field. Ping An’s doctor did not mention the investor of this round. On the same day, IDG’s Xiong Xiaoge mentioned in another forum that they were investors in Ping An’s doctor. Basically, it has been confirmed that IDG has participated in this round of financing. As the oldest VC in China, IDG is well-known for investing in excellent Internet companies such as Baidu, Tencent and Ctrip. In recent years, IDG's limelight has been robbed by Zhengge, Jingwei, Sequoia, etc. The main reason may be that IDG's investment style decision-making process is more complicated, and the valuation is conservative, so the ability to grab projects has declined. Such an investment institution that does not chase the bubble, it also recognizes the high price estimate of Ping An Good Doctor. External cause: The market is huge, and the doctors are safe and valued at 3 billion US dollars. 1. The domestic medical market is huge There are nearly 1.4 billion people in China, and the proportion of older people over the age of 65 has exceeded 10%. Many population studies have long pointed out that aging will become a major social issue. But for the medical industry , the demand for medical and health services in an aging society cannot be said to be a good news. Therefore, domestic Internet medical treatment is facing the world's largest market. 2. There are many problems in the existing medical system in China. Compared with the relatively sound medical environment in the United States, domestic basic medical care has many problems such as unreasonable medical system, lack of basic medical services, uneven distribution of medical resources, inadequate medical security, and insufficient coverage of commercial medical insurance. It can be said that it is well known by the contradiction between doctors and patients and the field of Putian. However, in the face of the interlocking problem, it is difficult to solve these problems in the current medical system. In this situation, exploring Internet medical care is almost the only way to balance supply and demand and solve these problems. And once Internet medical can effectively solve these problems, the value generated will far exceed that of foreign countries. Based on the above two points, the world's most valuable Internet medical company will definitely be produced in China, even if it is not today's safe doctor, sooner or later, it is also the bag of the registered network, Chunyu doctor, clove garden or any other company.
Plant extracts refer to substances extracted or processed from plants (all or a part of plants) using appropriate solvents or methods, and can be used in the pharmaceutical industry, food industry, daily chemical industry and other industries.
There is a conceptual overlap between plant extracts and herbal extracts. The raw materials of plant extracts in my country are mainly derived from Chinese herbal medicines, so domestic plant extracts can also be called Chinese medicine extracts to some extent.
Herbal Extract,Liquid Herbal Extracts,Herbal Extract Powder,Natural Herbal Extract XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.rhinebiotech.com
